17-40189320-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000620260.6(RAPGEFL1):c.1059G>T(p.Glu353Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,614,070 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E353Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000620260.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAPGEFL1 | NM_016339.6 | c.1059G>T | p.Glu353Asp | missense_variant | 6/15 | ENST00000620260.6 | NP_057423.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAPGEFL1 | ENST00000620260.6 | c.1059G>T | p.Glu353Asp | missense_variant | 6/15 | 1 | NM_016339.6 | ENSP00000479735 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152200Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251454Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135900
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.0000646 AC XY: 47AN XY: 727230
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152200Hom.: 1 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.441G>T (p.E147D) alteration is located in exon 6 (coding exon 4) of the RAPGEFL1 gene. This alteration results from a G to T substitution at nucleotide position 441, causing the glutamic acid (E) at amino acid position 147 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at